Georgia

We’ve been monitoring legislation in Georgia where lawmakers are continuing to consider legislation affecting hemp-derived products, including SB 33 and SB 34.

SB 33 (Monitoring)
Based on the latest developments, SB 33 appears to now be focused exclusively on prohibiting synthetic cannabinoids, including Delta-8 and similar compounds. Targeted enforcement against unlawful synthetic products is appropriate, and efforts to address bad actors in the marketplace are warranted.

SB 34 (Oppose)
However, SB 34 was totally gutted and replaced with language that would impose milligram caps and product restrictions on consumable hemp products that could significantly disrupt the existing marketplace. As discussed, proposals have included limits such as 5 mg THC caps for beverages and broader restrictions on product categories and container sizes.

While intended to create regulatory structure, these types of caps risk functioning as de facto limitations on lawful hemp products if not carefully calibrated to reflect real-world formulations and consumer use.

Georgia already operates under a regulatory framework for hemp products. Policymakers should focus on enforcement, testing, labeling, and age restrictions rather than adopting structural changes that could eliminate compliant full-spectrum products or disadvantage existing businesses.

Georgia Residents – Take Action: Contact your state lawmakers and urge them to support targeted enforcement against unlawful synthetic products while opposing unworkable THC caps or restrictions that would disrupt Georgia’s lawful hemp marketplace.